NasdaqCM - Nasdaq Real Time Price • USD
TRACON Pharmaceuticals, Inc. (TCON)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 5:59 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -1.19 | -1.09 | -4.62 | -3.43 |
| Low Estimate | -1.2 | -1.2 | -5.2 | -5.66 |
| High Estimate | -1.18 | -0.99 | -4.04 | -1.2 |
| Year Ago EPS | -7.2 | -4 | -2.2 | -4.62 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 1 | 2 |
| Avg. Estimate | -- | -- | -- | 1.75M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 3.5M |
| Year Ago Sales | -- | 9M | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -5.2 | -2 | -1.3 | -1.6 |
| EPS Actual | -7.2 | -4 | 5.8 | 0.2 |
| Difference | -2 | -2 | 7.1 | 1.8 |
| Surprise % | -38.50% | -100.00% | 546.20% | 112.50% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -1.19 | -1.09 | -4.62 | -3.43 |
| 7 Days Ago | -1.19 | -1.09 | -4.62 | -3.43 |
| 30 Days Ago | -0.06 | -0.05 | -0.23 | -0.07 |
| 60 Days Ago | -0.37 | -0.38 | -0.4 | -0.25 |
| 90 Days Ago | -0.37 | -0.38 | -0.4 | -0.25 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 1 | 1 | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | TCON | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 83.50% | -- | -- | 6.50% |
| Next Qtr. | 72.80% | -- | -- | 12.00% |
| Current Year | -110.00% | -- | -- | 5.30% |
| Next Year | 25.80% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 4/3/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/6/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/20/2023 |
| Downgrade | JonesTrading: Buy to Hold | 8/21/2023 |
| Maintains | Baird: Outperform to Outperform | 8/15/2023 |
| Maintains | Maxim Group: Buy | 5/11/2023 |
Related Tickers
NRXP NRx Pharmaceuticals, Inc.
3.5400
+12.74%
EYEN Eyenovia, Inc.
0.6282
-11.68%
ASLN ASLAN Pharmaceuticals Limited
0.4153
-7.30%
GLMD Galmed Pharmaceuticals Ltd.
0.3916
+0.90%
RVPH Reviva Pharmaceuticals Holdings, Inc.
2.9900
+0.34%
CDTX Cidara Therapeutics, Inc.
12.63
-2.85%
CNTB Connect Biopharma Holdings Limited
1.3400
-0.74%
KTRA Kintara Therapeutics, Inc.
0.1488
-5.82%
JAGX Jaguar Health, Inc.
0.1800
+5.88%
NKGN NKGen Biotech, Inc.
1.6100
-18.69%